Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Translational medicine

Double protection for weakened bones

The protein Sema3A both restrains bone degradation and stimulates bone building in mice, suggesting a potential therapy for conditions such as osteoporosis. See Article p.69

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1: Coupling bone synthesis and degradation.


  1. Zaidi, M. Nature Med. 13, 791–801 (2007).

    Article  CAS  Google Scholar 

  2. Hayashi, M. et al. Nature 485, 69–74 (2012).

    Article  ADS  CAS  Google Scholar 

  3. Potiron, V. & Roche, J. Sci. STKE 285, pe24 (2005).

    Google Scholar 

  4. He, Z. & Tessier-Lavigne, M. Cell 90, 739–751 (1997).

    Article  CAS  Google Scholar 

  5. Mendes-da-Cruz, D. A. et al. Exp. Physiol. (2012).

  6. Chakraborty, G. et al. PLoS ONE 7, e33633 (2012).

    Article  ADS  CAS  Google Scholar 

  7. Pasterkamp, R. J. et al. Exp. Neurol. 153, 313–327 (1998).

    Article  CAS  Google Scholar 

  8. Maione, F. et al. J. Clin. Invest. 119, 3356–3372 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Mone Zaidi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zaidi, M., Iqbal, J. Double protection for weakened bones. Nature 485, 47–48 (2012).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research